Bulk Manufacturer of Controlled Substances Application: SpecGx LLC, 19990 [2023-06952]
Download as PDF
<![CDATA[
19990
Federal Register / Vol. 88, No. 64 / Tuesday, April 4, 2023 / Notices
DEPARTMENT OF JUSTICE
Controlled substance
Drug
code
Schedule
drug codes are authorized for this
registration.
9634
9821
I
I
Matthew Strait,
Deputy Assistant Administrator.
Drug Enforcement Administration
[Docket No. DEA–1176]
Bulk Manufacturer of Controlled
Substances Application: SpecGx LLC
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
SpecGx LLC has applied to be
registered as a bulk manufacturer of
basic class(es) of controlled
substance(s). Refer to SUPPLEMENTARY
INFORMATION listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before June 5, 2023. Such persons
may also file a written request for a
hearing on the application on or before
June 5, 2023.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.33(a), this
is notice that on February 14, 2023,
SpecGx LLC, 3600 North 2nd Street,
Saint Louis, Missouri 63147–3457,
applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substance(s):
SUMMARY:
ddrumheller on DSK120RN23PROD with NOTICES1
Controlled substance
Gamma Hydroxybutyric
Acid.
Tetrahydrocannabinols ...
Psilocybin .......................
Codeine-N-oxide .............
Noroxymorphone ............
Difenoxin .........................
Morphine-N-oxide ...........
Normorphine ...................
Alphamethadol ................
Betamethadol .................
VerDate Sep<11>2014
Drug
code
Schedule
2010
I
7370
7437
9053
9145
9168
9307
9313
9605
9609
I
I
I
I
I
I
I
I
I
19:41 Apr 03, 2023
Jkt 259001
Norlevorphanol ...............
Acetyl Fentanyl (N-(1phenethylpiperidin-4yl)-N-phenylacetamide).
Butyryl Fentanyl ..............
Fentanyl related-compounds as defined in
21 CFR 1308.11(h).
Amphetamine .................
Methamphetamine ..........
Lisdexamfetamine ..........
Methylphenidate .............
Nabilone .........................
ANPP (4-Anilino-Nphenethyl-4-piperidine).
Phenylacetone ................
Codeine ..........................
Dihydrocodeine ...............
Oxycodone .....................
Hydromorphone ..............
Diphenoxylate .................
Ecgonine .........................
Hydrocodone ..................
Levorphanol ....................
Isomethadone .................
Meperidine ......................
Meperidine intermediateA.
Meperidine intermediateB.
Meperidine intermediateC.
Methadone ......................
Methadone intermediate
Dextropropoxyphene,
bulk (non-dosage
forms).
Morphine .........................
Oripavine ........................
Thebaine .........................
Opium tincture ................
Opium, powdered ...........
Oxymorphone .................
Noroxymorphone ............
Alfentanil .........................
Remifentanil ....................
Sufentanil ........................
Tapentadol ......................
Fentanyl ..........................
Amphetamine .................
Methamphetamine ..........
Lisdexamfetamine ..........
Methylphenidate .............
Pentobarbital ..................
4-Anilino-N-Phenethyl-4Piperidine (ANPP).
Tapentadol ......................
Fentanyl ..........................
[FR Doc. 2023–06952 Filed 4–3–23; 8:45 am]
9822
9850
I
I
1100
1105
1205
1724
7379
8333
II
II
II
II
II
II
8501
9050
9120
9143
9150
9170
9180
9193
9220
9226
9230
9232
II
II
II
II
II
II
II
II
II
II
II
II
9233
II
9234
II
9250
9254
9273
II
II
II
9300
9330
9333
9630
9639
9652
9668
9737
9739
9740
9780
9801
1100
1105
1205
1724
2270
8333
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
9780
9801
II
II
DEPARTMENT OF LABOR
The company plans to bulk
manufacture the listed controlled
substances for sale to its customers as
Active Pharmaceutical Ingredients
(APIs) and Analytical Research
Standards (ARS) for formulation and
analytical development purposes. In
reference to dug codes 7360
(Marihuana), and 7370
(Tetrahydrocannabinols), the company
plans to bulk manufacture these drugs
as synthetic. No other activities for these
PO 00000
Frm 00088
Fmt 4703
BILLING CODE 4410–09–P
Sfmt 4703
Occupational Safety and Health
Administration
[Docket No. OSHA–2018–0005]
Whistleblower Stakeholder Meeting:
Outreach and Training
Occupational Safety and Health
Administration (OSHA), Labor.
ACTION: Notice of public meeting.
AGENCY:
The Occupational Safety and
Health Administration (OSHA) is
announcing a public meeting to solicit
comments and suggestions from
stakeholders on its outreach and
training efforts in support of the
whistleblower laws it enforces.
DATES: The public meeting will be held
on May 10, 2023, from 1:00 p.m. to 4:00
p.m., ET via Zoom. Persons interested in
attending the meeting must register by
May 3, 2023. In addition, comments
relating to the ‘‘Scope of Meeting’’
section of this document must be
submitted by May 24, 2023.
ADDRESSES:
Electronically: You may submit
materials, including attachments,
electronically at https://
www.regulations.gov, which is the
Federal eRulemaking portal. Follow the
on-line instructions for submissions. All
comments should be identified with
Docket No. OSHA–2018–0005.
Registration to Attend and/or to
Participate in the Meeting: If you wish
to attend the public meeting, make an
oral presentation at the meeting, or
participate in the meeting, you must
register using this link https://
www.eventbrite.com/e/whistlebloweroutreach-stakeholder-meeting-tickets558199739447 or this link for
registration in Spanish https://
www.eventbrite.com/e/entradasreunion-para-partes-interesadas-sobrelos-denunciantes-que-son-trabajadores558210240857 by close of business on
May 3, 2023. Each participant will be
allowed to speak for up to 5 minutes. If
there is extra time at the end of the
meeting, participants may be given extra
time to speak. There is no fee to register
for the public meeting. After reviewing
the requests to present, OSHA will
contact each participant prior to the
meeting to inform them of the speaking
SUMMARY:
E:\FR\FM\04APN1.SGM
04APN1
]]>Agencies
[Federal Register Volume 88, Number 64 (Tuesday, April 4, 2023)]
[Notices]
[Page 19990]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-06952]
[[Page 19990]]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1176]
Bulk Manufacturer of Controlled Substances Application: SpecGx
LLC
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: SpecGx LLC has applied to be registered as a bulk manufacturer
of basic class(es) of controlled substance(s). Refer to Supplementary
Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
June 5, 2023. Such persons may also file a written request for a
hearing on the application on or before June 5, 2023.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to https://www.regulations.gov and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on https://www.regulations.gov. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on February 14, 2023, SpecGx LLC, 3600 North 2nd Street,
Saint Louis, Missouri 63147-3457, applied to be registered as a bulk
manufacturer of the following basic class(es) of controlled
substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid.............. 2010 I
Tetrahydrocannabinols.................. 7370 I
Psilocybin............................. 7437 I
Codeine-N-oxide........................ 9053 I
Noroxymorphone......................... 9145 I
Difenoxin.............................. 9168 I
Morphine-N-oxide....................... 9307 I
Normorphine............................ 9313 I
Alphamethadol.......................... 9605 I
Betamethadol........................... 9609 I
Norlevorphanol......................... 9634 I
Acetyl Fentanyl (N-(1- 9821 I
phenethylpiperidin-4-yl)-N-
phenylacetamide).
Butyryl Fentanyl....................... 9822 I
Fentanyl related-compounds as defined 9850 I
in 21 CFR 1308.11(h).
Amphetamine............................ 1100 II
Methamphetamine........................ 1105 II
Lisdexamfetamine....................... 1205 II
Methylphenidate........................ 1724 II
Nabilone............................... 7379 II
ANPP (4-Anilino-N-phenethyl-4- 8333 II
piperidine).
Phenylacetone.......................... 8501 II
Codeine................................ 9050 II
Dihydrocodeine......................... 9120 II
Oxycodone.............................. 9143 II
Hydromorphone.......................... 9150 II
Diphenoxylate.......................... 9170 II
Ecgonine............................... 9180 II
Hydrocodone............................ 9193 II
Levorphanol............................ 9220 II
Isomethadone........................... 9226 II
Meperidine............................. 9230 II
Meperidine intermediate-A.............. 9232 II
Meperidine intermediate-B.............. 9233 II
Meperidine intermediate-C.............. 9234 II
Methadone.............................. 9250 II
Methadone intermediate................. 9254 II
Dextropropoxyphene, bulk (non-dosage 9273 II
forms).
Morphine............................... 9300 II
Oripavine.............................. 9330 II
Thebaine............................... 9333 II
Opium tincture......................... 9630 II
Opium, powdered........................ 9639 II
Oxymorphone............................ 9652 II
Noroxymorphone......................... 9668 II
Alfentanil............................. 9737 II
Remifentanil........................... 9739 II
Sufentanil............................. 9740 II
Tapentadol............................. 9780 II
Fentanyl............................... 9801 II
Amphetamine............................ 1100 II
Methamphetamine........................ 1105 II
Lisdexamfetamine....................... 1205 II
Methylphenidate........................ 1724 II
Pentobarbital.......................... 2270 II
4-Anilino-N-Phenethyl-4-Piperidine 8333 II
(ANPP).
Tapentadol............................. 9780 II
Fentanyl............................... 9801 II
------------------------------------------------------------------------
The company plans to bulk manufacture the listed controlled
substances for sale to its customers as Active Pharmaceutical
Ingredients (APIs) and Analytical Research Standards (ARS) for
formulation and analytical development purposes. In reference to dug
codes 7360 (Marihuana), and 7370 (Tetrahydrocannabinols), the company
plans to bulk manufacture these drugs as synthetic. No other activities
for these drug codes are authorized for this registration.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2023-06952 Filed 4-3-23; 8:45 am]
BILLING CODE 4410-09-P
